Latest Pro-Life News

On Sept. 30, hours before the federal government shut down, the U.S. Food and Drug Administration had a baffling act to fit in. The FDA stealthily approved a new generic version of the abortion drug mifepristone.

Mifepristone, a drug the FDA itself admits sends as many as 1 in 25 women to the emergency room even under strict use conditions, is not only responsible for the deaths of countless unborn children, but also has taken the lives of too many mothers along with it.

Ironically, the approval came barely a week after the administration warned pregnant women to reconsider taking Tylenol to avoid harm to their unborn children.

Evita Solutions, which describes its mission as being to “destigmatize abortion” and make abortions accessible “for all,” submitted its application to produce generic mifepristone in October 2021 ‒ mere months after then-President Joe Biden’s FDA used COVID-19 as an excuse to ditch the safeguard of in-person doctor visits to obtain abortion drugs.

No doubt a profitable opportunity was in sight. Today, there are at least 1.1 million abortions a year in America, and more than 60% are carried out using drugs.

Taking doctors out of the equation, the abortion industry will happily sell dangerous drugs to anyone over the internet, completely free of face-to-face interaction with a clinician. Lack of access is clearly not a problem…